Concepedia

Carly J. King

CJ

Statistics

Publications

6

Citations

365

H-Index

6

Active since

2015

Affiliations

Oregon Health & Science University(Current)

Carly J. King is an author at Oregon Health & Science University specializing in oncology, molecular oncology, and prostate cancer.

Publications per year

2015–2019

6

Publications

6

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Archana Sehrawat, Lina Gao, Yuliang Wang et al. · Proceedings of the National Academy of Sciences · 2018 · 229 citations · Full text

, , +17

Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma

Hui-Wen Lue, Brook C. Cole, Soumya Rao et al. · Oncotarget · 2015 · 36 citations · Full text

, , +11

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

Daniel J. Coleman, Lina Gao, Jacob Schwartzman et al. · Scientific Reports · 2019 · 36 citations · Full text

, , +17

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer

Daniel J. Coleman, Lina Gao, Carly J. King et al. · Oncogene · 2019 · 27 citations · Full text

, , +15

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Daniel J. Coleman, Kathryn Van Hook, Carly J. King et al. · Oncotarget · 2016 · 22 citations · Full text

, , +15

1–5 of 6